nvs
☆    

India,
2008-02-19 07:11
(edited by Ohlbe on 2008-02-19 21:46)

Posting: # 1621
Views: 2,278
 

 Type of studies etc. [Dissolution / BCS / IVIVC]

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,780 posts in 4,196 threads, 1,358 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 18:07 CEST

If you obey all the rules,
you will miss all the fun.    Katharine Hepburn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5